Revolutionary Cardiac Neuroablation Achieved in Abu Dhabi

Cleveland Clinic Abu Dhabi has achieved a significant milestone by successfully conducting the first cardiac neuroablation procedure in the UAE, representing an important development in cutting-edge cardiac treatment. This minimally invasive technique provides an innovative solution for patients who experience frequent fainting due to abnormal heart rhythms, and can often eliminate the need for a permanent pacemaker.

Currently offered at only a select number of premier cardiac centers globally, cardiac neuroablation addresses the root causes of heart rhythm disorders associated with the autonomic nervous system, moving beyond merely managing symptoms with long-term devices.

This pioneering treatment focuses on correcting abnormal nerve signals tied to the overactivity of the vagus nerve, which can abruptly decrease heart rate and blood pressure, leading to repeated fainting incidents. By precisely modifying these nerve pathways, physicians can restore a consistent heart rhythm through a targeted and minimally invasive method.

Dr. Georges-Pascal Haber, CEO of Cleveland Clinic Abu Dhabi, remarked that this milestone showcases the hospital's dedication to providing excellence in cardiac care, further positioning Abu Dhabi as a hub for specialized healthcare services in the region.

The innovative procedure was performed on a 48-year-old patient plagued by frequent fainting spells that disrupted her daily life and personal safety. Instead of opting for a permanent pacemaker, the medical team chose cardiac neuroablation to target the underlying cause directly.

Dr. Fereidoon Shafiei, a physician in the Cardiovascular Medicine Department, emphasized that the introduction of cardiac neuroablation marks a significant leap in heart healthcare within the UAE. He noted it enables doctors to accurately target irregular heartbeat pathways and can effectively cease recurrent fainting spells without the need for permanent devices for many individuals.

The procedure is performed using specialized catheters inserted through blood vessels leading to the heart. Advanced mapping techniques allow clinicians to identify and specifically modify troublesome nerve pathways responsible for irregular heart rhythms, all without the necessity of open-heart surgery.

Dr. Khalid Bakr, also part of the Cardiovascular Medicine team, indicated that this highly specialized catheter-based approach can considerably enhance patients' quality of life by diminishing or entirely eradicating fainting episodes.

Post-surgery, the patient exhibited immediate improvement with a steady heart rhythm noted during follow-up evaluations. She successfully resumed her regular activities and reported better energy levels and overall quality of life.

The successful application of cardiac neuroablation underscores Abu Dhabi's emerging significance in integrating advanced medical breakthroughs into routine clinical practice, reflecting a broader transition towards precise and patient-centric healthcare solutions.